I am understanding Alzheimer's

Alzheimer's causes problems with memory, thinking, and behavior

 

Diagnosing Alzheimer's often involves multiple tests
LEARN MORE >
Alzheimer's is progressive and gets worse over time
WHAT ELSE TO EXPECT >
2 types of Alzheimer's medications are currently available
SEE TREATMENT OPTIONS >

There are a number of ways to help confirm a diagnosis of Alzheimer's

Once a medical and health history has been obtained, the doctor may ask your loved one to undergo a more thorough evaluation, This may include:

  • A routine physical exam
  • A brain scan
  • A neuropsychological evaluation
  • An exam that tests physical sensations controlled by the nervous system

Several tests may help point to an Alzheimer's diagnosis

There is no single test that can definitively confirm your loved one has Alzheimer's disease. However, there are 3 assessments that doctors may use to help diagnose their conditions.

 

1

Clock Drawing Test (CDT)

2

Mini-Mental State Examination (MMSE)

3

Functional Assessment Staging Tool (FAST)

 

See benefits of NAMENDA XR

Be on the lookout for any changes in your loved one's symptoms

If you notice any changes in symptoms, make an appointment with the doctor as soon as you can. That way, the doctor can make an informed decision about whether it's time to add NAMENDA XR® to your loved one's treatment for moderate to severe Alzheimer's disease.

Symptoms of moderate stage Alzheimer's

  • Increased memory loss and confusion
  • Problems recognizing family and friends
  • Continuously repeating stories, favorite wants, or motions
  • Difficulty doing things that have multiple steps, like getting dressed
  • Lack of concern for hygiene and appearance

Symptoms of severe stage Alzheimer's

  • Inability to recognize oneself or family
  • Inability to communicate
  • Lack of control over bowel and bladder
  • Groaning, moaning, or grunting
  • Needing help with all activities of daily living

 

There is no evidence that NAMENDA XR or an AChEI prevents or slows down the underlying disease process in patients with Alzheimer's disease.

Go to the Symptom Recognition Tool

Two medications are available for Alzheimer's

There is no evidence that NAMENDA XR or an AChEI prevents or slows the underlying disease process in patients with Alzheimer's disease.

*ARICEPT is a registered trademark of Eisai Co., Ltd.
RAZADYNE is a registered trademark of Johnson & Johnson.
EXELON is a registered trademark of Novartis AG Corp.

Next: Taking Action

There is no evidence that NAMENDA XR prevents or slows the underlying disease process in patients with Alzheimer's disease.

Important Risk Information
Who should NOT take NAMENDA XR?

NAMENDA XR should not be taken by anyone who is allergic (hypersensitive) to memantine, the active substance in NAMENDA XR, or who has had a bad reaction to NAMENDA XR or any of its ingredients.

What should be discussed with the healthcare provider before taking NAMENDA XR?

Before starting NAMENDA XR, talk to the healthcare provider about all of the patient's past and present medical conditions, including:

If the patient is taking other medications (including those without a prescription), ask the healthcare provider if NAMENDA XR is right for the patient.

What are the possible side effects of NAMENDA XR?

The most common side effects associated with NAMENDA XR treatment are headache, diarrhea, and dizziness. This is not a complete list of side effects.

Indication

NAMENDA XR extended-release capsules are approved for the treatment of moderate to severe Alzheimer's disease. NAMENDA XR is available by prescription only.

Please see full Prescribing Information, including Patient Information.